Transition from hepatic steatosis to steatohepatitis: Unique microRNA patterns and potential downstream functions and pathways

Journal of Gastroenterology and Hepatology (Australia)

Volumn 27, Issue 2, 2012, Pages 331-340

  Jin, Xi ^a   Chen, Yi peng ^a   Kong, Mei ^a   Zheng, Lin ^a   Yang, Yi da ^a   Li, You ming ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Gene ontology; Microarray; MicroRNA; Non alcoholic steatohepatitis; Steatosis

Indexed keywords

MICRORNA; MICRORNA 103; MICRORNA 106B; MICRORNA 128B; MICRORNA 130A; MICRORNA 138; MICRORNA 145; MICRORNA 146A; MICRORNA 153; MICRORNA 190; MICRORNA 192; MICRORNA 196A; MICRORNA 196B; MICRORNA 19B; MICRORNA 210; MICRORNA 214; MICRORNA 218; MICRORNA 22; MICRORNA 29A; MICRORNA 29C; MICRORNA 300; MICRORNA 30B; MICRORNA 31; MICRORNA 33; MICRORNA 339; MICRORNA 342; MICRORNA 34A; MICRORNA 93; UNCLASSIFIED DRUG;

ACCURACY; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BIOINFORMATICS; CONTROLLED STUDY; DOWN REGULATION; FATTY ACID METABOLISM; GENE TARGETING; GENETIC DATABASE; HOMEOSTASIS; MICROARRAY ANALYSIS; NONALCOHOLIC FATTY LIVER; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

EID: 84862908613     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2011.06864.x     Document Type: Article

References (37)

1. Angulo P. Nonalcoholic fatty liver disease. N. Engl. J. Med. 2002; 346: 1221-31.
2. Bellentani S, Marino M. Epidemiology and natural history of non-alcoholic fatty liver disease (NAFLD). Ann. Hepatol. 2009; 8 (Suppl. 1): S4-8.
3. Fan JG, Farrell GC. Epidemiology of non-alcoholic fatty liver disease in China. J. Hepatol. 2009; 50: 204-10.
4. Day CP, James OF. Steatohepatitis: a tale of two "hits"? Gastroenterology 1998; 114: 842-5.
5. Lau NC, Lim LP, Weinstein EG, Bartel DP. An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 2001; 294: 858-62.
6. Ambros V. The functions of animal microRNAs. Nature 2004; 431: 350-5.
7. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993; 75: 843-54.
8. Pasquinelli AE, Reinhart BJ, Slack F etal. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 2000; 408: 86-9.
9. Jay C, Nemunaitis J, Chen P, Fulgham P, Tong AW. miRNA profiling for diagnosis and prognosis of human cancer. DNA Cell Biol. 2007; 26: 293-300.
10. Jin X, Ye YF, Chen SH, Yu CH, Liu J, Li YM. MicroRNA expression pattern in different stages of nonalcoholic fatty liver disease. Dig. Liver Dis. 2009; 41: 289-97.
11. Dolganiuc A, Petrasek J, Kodys K etal. MicroRNA expression profile in Lieber-DeCarli diet-induced alcoholic and methionine choline deficient diet-induced nonalcoholic steatohepatitis models in mice. Alcohol. Clin. Exp. Res. 2009; 33: 1704-10.
12. Torres DM, Harrison SA. Diagnosis and therapy of nonalcoholic steatohepatitis. Gastroenterology 2008; 134: 1682-98.
13. Jin X, Yu CH, Lv GC, Li YM. Increased intestinal permeability in pathogenesis and progress of nonalcoholic steatohepatitis in rats. World J. Gastroenterol. 2007; 13: 1732-6.
14. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am. J. Gastroenterol. 1999; 94: 2467-74.
15. Chen C, Ridzon DA, Broomer AJ etal. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 2005; 33: e179.
16. Griffiths-Jones S. The microRNA registry. Nucleic Acids Res. 2004; 32: D109-11.
17. Olson NE. The microarray data analysis process: from raw data to biological significance. NeuroRx 2006; 3: 373-83.
18. Tibshirani R, Hastie T, Narasimhan B, Chu G. Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc. Natl. Acad. Sci. U S A 2002; 99: 6567-72.
19. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. U S A 1998; 95: 14863-8.
20. Huang da W, Sherman BT, Tan Q etal. DAVID Bioinformatics Resources: expanded annotation database and novel algorithms to better extract biology from large gene lists. Nucleic Acids Res. 2007; 35: W169-75.
21. Ekstedt M, Franzen LE, Mathiesen UL etal. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 2006; 44: 865-73.
22. Cheung O, Puri P, Eicken C etal. Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression. Hepatology 2008; 48: 1810-20.
23. Hurst DR, Edmonds MD, Scott GK, Benz CC, Vaidya KS, Welch DR. Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis. Cancer Res. 2009; 69: 1279-83.
24. Valastyan S, Weinberg RA. miR-31: a crucial overseer of tumor metastasis and other emerging roles. Cell Cycle 2010; 9: 2124-9.
25. Li Y, Tan W, Neo TW etal. Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma. Cancer Sci. 2009; 100: 1234-42.
26. Chen X, Guo X, Zhang H etal. Role of miR-143 targeting KRAS in colorectal tumorigenesis. Oncogene 2009; 28: 1385-92.
27. Tsai KW, Hu LY, Wu CW etal. Epigenetic regulation of miR-196b expression in gastric cancer. Genes Chromosomes Cancer 2010; 49: 969-80.
28. Rane S, He M, Sayed D etal. Downregulation of miR-199a derepresses hypoxia-inducible factor-1alpha and Sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes. Circ. Res. 2009; 104: 879-86.
29. Huang X, Le QT, Giaccia AJ. MiR-210-micromanager of the hypoxia pathway. Trends Mol. Med. 2010; 16: 230-7.
30. Guo CJ, Pan Q, Li DG, Sun H, Liu BW. miR-15b and miR-16 are implicated in activation of the rat hepatic stellate cell: an essential role for apoptosis. J. Hepatol. 2009; 50: 766-78.
31. Karbiener M, Fischer C, Nowitsch S etal. microRNA miR-27b impairs human adipocyte differentiation and targets PPARgamma. Biochem. Biophys. Res. Commun. 2009; 390: 247-51.
32. Wilfred BR, Wang WX, Nelson PT. Energizing miRNA research: a review of the role of miRNA in lipid metabolism, with a prediction that miR-103/107 regulates human metabolic pathways. Mol. Genet. Metab. 2007; 91: 209-17.
33. Pogribny IP, Starlard-Davenport A, Tryndyak VP etal. Difference in expression of hepatic microRNAs miR-29c, miR-34a, miR-155, and miR-200b is associated with strain-specific susceptibility to dietary nonalcoholic steatohepatitis in mice. Lab. Invest. 2010; 90: 1437-46.
34. Tang Y, Banan A, Forsyth CB etal. Effect of alcohol on miR-212 expression in intestinal epithelial cells and its potential role in alcoholic liver disease. Alcohol. Clin. Exp. Res. 2008; 32: 355-64.
35. Lawrie CH, Gal S, Dunlop HM etal. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br. J. Haematol. 2008; 141: 672-5.
36. Alisi A, Da Sacco L, Bruscalupi G etal. Mirnome analysis reveals novel molecular determinants in the pathogenesis of diet-induced nonalcoholic fatty liver disease. Lab. Invest. 2011; 91: 283-93.
37. Jin X, Yang YD, Chen K etal. HDMCP uncouples yeast mitochondrial respiration and alleviates steatosis in L02 and hepG2 cells by decreasing ATP and H2O2 levels: a novel mechanism for NAFLD. J. Hepatol. 2009; 50: 1019-28.